Cis-resveratrol Decreases Blood Clotting
March 11th, 2010 | Author: admin
Drs. A.A. Bertelli, L. Giovannini, W. Bemini, M. Migliori, M. Fregoni, L. Bavaresco, and A. Bertelli at the Institute of Anatomy at University of Milan, Italy have evaluated the anti-blood clotting effect of cis-resveratrol, a type of the antiaging compound resveratrol found in red wine.
In 1996, these doctors evaluated the anti-blood clotting activities of cis-resveratrol in a laboratory environment in different concentrations on blood-platelet rich plasma. Cis-resveratrol was able to decrease toxin-induced blood platelet clotting, while trans-resveratrol at the same concentration had a lower efficiency rate. However, both types of resveratrol were observed to cause a decrease in blood clotting, a common condition experienced by aging adults.
In this study, both of these have effective properties in biological fluids, such as blood platelet rich plasma. The evaluation of resveratrol activity in animals and humans takes into account the total amount of both cis- and trans-resveratrol. Cis- and trans-resveratrol, like resveratrol, can be consumed by drinking red wine or taking resveratrol supplements, in the form of tablets, pills or lozenges.